MoneyWorks4Me

Shilpa Medicare - Quaterly Results

11 Aug 2022 Evaluate
The sales for the June 2022 quarter moved down -42.34% to Rs. 608.34 millions as compared to Rs. 1055.00 millions during the year ago period.A big decline of -56.45% was reported for the quarter ended June 2022 to Rs. 38.54  millions from Rs. 88.49 millions of corresponding previous quarter.Operating profit for the quarter ended June 2022 decreased to 171.30 millions as compared to 222.27 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 608.34 1055.00 -42.34 608.34 1055.00 -42.34 3569.52 2570.50 38.86
Other Income 126.28 93.98 34.37 126.28 93.98 34.37 408.62 322.46 26.72
PBIDT 171.30 222.27 -22.93 171.30 222.27 -22.93 625.49 656.16 -4.67
Interest 26.59 24.90 6.79 26.59 24.90 6.79 90.54 60.74 49.06
PBDT 144.71 197.37 -26.68 144.71 197.37 -26.68 623.04 1124.90 -44.61
Depreciation 104.21 71.10 46.57 104.21 71.10 46.57 348.18 222.81 56.27
PBT 40.50 126.27 -67.93 40.50 126.27 -67.93 274.86 902.09 -69.53
TAX 1.96 37.78 -94.81 1.96 37.78 -94.81 73.27 251.17 -70.83
Deferred Tax -5.14 4.88 -205.33 -5.14 4.88 -205.33 25.25 93.37 -72.96
PAT 38.54 88.49 -56.45 38.54 88.49 -56.45 201.59 650.92 -69.03
Equity 86.80 81.53 6.46 86.80 81.53 6.46 86.80 81.53 6.46
PBIDTM(%) 28.16 21.07 33.65 28.16 21.07 33.65 17.52 25.53 -31.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..